Table 1 Patients’ and control cohort characteristics
From: High-sensitive Troponin T increase after exercise in patients with pulmonary arterial hypertension
n = 24 | Mean ± SD |
|---|---|
Age (years) | 57.27 ± 16.33 |
Male (%) | 65 |
IPAH (%) | 60 |
CTEPH (%) | 40 |
BMI (kg/cm2) | 27,17 ± 6.45 |
SvO2 (%) | 62.86 ± 7.92 |
PAmean (mmHg) | 48.72 ± 18.69 |
PVR (dyn*s*cm-5) | 638.18 ± 381.06 |
Mean RAP (mmHg) | 10.82 ± 4.63 |
Workload max (Watt) | 74.61 ± 21.07 |
Peak VO2 (ml/kg/min) | 13.32 ± 3.3 |
SysRRmax (mmHg) | 153.56 ± 32.42 |
NT-proBNP (ng/L) | 363.39 ± 461.68 |
6-MWT (m) | 428.52 ± 118.96 |
Ejection fraction (%) | 55.13 ± 4.34 |
Diastolic LV-dysfunction (%) | 41.67 |
History of CAD (%) | 12.5 |
Creatinin (mg/dL) | 1.12 ± 0.83 |
Control cohort characteristics | |
n = 12 | mean ± SD |
Age (years) | 36.8 ± 10.7 |
Male (%) | 58 |
Workload max (Watt) | 244.58 ± 60.56 |
Peak VO2 (ml/kg/min) | 38.73 ± 11.34 |
NT-proBNP (ng/L) | 31.65 ± 42.49 |